Literature DB >> 11606930

Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?

M Braun-Falco1, W Volgger, S Borelli, J Ring, R Disch.   

Abstract

Galli-Galli disease is an inherited disease characterized by slowly progressive and disfiguring reticulate hyperpigmentation of the flexures, clinically and histopathologically diagnostic for Dowling-Degos disease, but also associated with suprabasal, nondyskeratotic acantholysis. A few patients exhibiting these features have been described, mainly in the non-English-language literature, which suggests that Galli-Galli disease is not an entity of its own, as originally thought, but is an acantholytic variant of Dowling-Degos disease. We report a typical case of Galli-Galli disease, which supports this concept.

Entities:  

Mesh:

Year:  2001        PMID: 11606930     DOI: 10.1067/mjd.2001.116340

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

1.  Presentation of reticulate acropigmentation of kitamura and dowling-degos disease overlap.

Authors:  Jennifer C Tang; Julia Escandon; Michael Shiman; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2012-05

2.  [Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients].

Authors:  S Hanneken; A Rütten; S Eigelshoven; M Braun-Falco; S M Pasternack; T Ruzicka; M M Nöthen; R C Betz; R Kruse
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

3.  Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease.

Authors:  Regina C Betz; Laura Planko; Sibylle Eigelshoven; Sandra Hanneken; Sandra M Pasternack; Heinrich Bussow; Kris Van Den Bogaert; Joerg Wenzel; Markus Braun-Falco; Arno Rutten; Michael A Rogers; Thomas Ruzicka; Markus M Nöthen; Thomas M Magin; Roland Kruse
Journal:  Am J Hum Genet       Date:  2006-01-19       Impact factor: 11.025

Review 4.  The molecular basis of human keratin disorders.

Authors:  Meral Julia Arin
Journal:  Hum Genet       Date:  2009-02-27       Impact factor: 4.132

5.  Galli-galli disease: a rare acantholytic variant of dowling-degos disease.

Authors:  J Gomes; J Labareda; I Viana
Journal:  Case Rep Med       Date:  2011-05-05

6.  Acitretin therapy for Galli-Galli disease.

Authors:  Chandler W Rundle; Solveig Ophaug; Eric L Simpson
Journal:  JAAD Case Rep       Date:  2020-04-30

7.  The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.

Authors:  Shyam Verma; Sandra M Pasternack; Arno Rütten; Thomas Ruzicka; Regina C Betz; Sandra Hanneken
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.